Danish monkeypox vaccine maker widens deal with Canada
Stay tuned with 24 News HD Android App
The agreement with Canada's public health agency is worth about $234 million, with an additional $180 million in contract options for further doses over 10 years, the company said in a statement.
A multi-year deal valued up to $20 million was also signed with the country's defence department.
Bavarian Nordic said the majority of the doses will be delivered in 2023.
According to the data from the World Health Organization (WHO), as of September 19, there were 61,753 confirmed cases and 23 associated deaths in more than 100 countries, the vast majority of which are in Europe and North America.
However, since mid-August the number of new daily cases has been slowing.
Monkeypox is not usually fatal but often manifests itself through fever, muscle aches, swollen lymph nodes, chills, exhaustion and a chickenpox-like rash on the hands and face.
Nearly all the cases so far have been among men who have sex with men, and the WHO has cautioned against stigmatisation of those infected, stressing that the disease can affect anyone.